{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:04:21Z","timestamp":1787753061835,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11096-020-01030-3","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T07:03:42Z","timestamp":1588143822000},"page":"931-937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of goserelin effectiveness based on assessment of inflammatory cytokines and symptoms in uterine leiomyoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Nadia H.","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2183-6830","authenticated-orcid":false,"given":"Anmar","family":"Al-Taie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa","family":"Albasry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"1030_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/IJWH.S51083","volume":"6","author":"AT Khan","year":"2014","unstructured":"Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current perspectives. Int J Womens Health. 2014;6:95\u2013114","journal-title":"Int J Womens Health"},{"key":"1030_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bpobgyn.2008.01.005","volume":"22","author":"R Fleischer","year":"2008","unstructured":"Fleischer R, Weston GC, Vollenhoven BJ, Rogers PA. Pathophysiology of fibroid disease: angiogenesis and regulation of smooth muscle proliferation. Best Pract Res Clin Obstet Gynaecol. 2008;22:603\u201314","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1030_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","volume":"22","author":"S Okolo","year":"2008","unstructured":"Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22:571\u201388","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"211","key":"1030_CR4","first-page":"e1","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(211):e1\u20139","journal-title":"Am J Obstet Gynecol"},{"key":"1030_CR5","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1056\/NEJMra1209993","volume":"369","author":"SE Bulun","year":"2013","unstructured":"Bulun SE. Uterine fibroids. N Engl J Med. 2013;369:1344\u201355","journal-title":"N Engl J Med"},{"key":"1030_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1055\/s-0030-1251476","volume":"28","author":"N Chegini","year":"2010","unstructured":"Chegini N. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic. Semin Reprod Med. 2010;28:180\u2013203","journal-title":"Semin Reprod Med"},{"key":"1030_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/humrep\/deu300","volume":"30","author":"Y Wang","year":"2015","unstructured":"Wang Y, Feng G, Wang J, Zhou Y, Liu Y, Shi Y, et al. Differential effects of tumor necrosis factor-\u03b1 on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells. Hum Reprod. 2015;30:61\u201370","journal-title":"Hum Reprod"},{"key":"1030_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1359-6101(03)00022-4","volume":"14","author":"K Pfeffer","year":"2003","unstructured":"Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 2003;14:185\u201391","journal-title":"Cytokine Growth Factor Rev"},{"key":"1030_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1253\/circj.68.671","volume":"68","author":"KF Kusano","year":"2004","unstructured":"Kusano KF, Nakamura K, Kusano H, Nishii N, Banba K, Ikeda T, et al. Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis. Circ J. 2004;68:671\u20136","journal-title":"Circ J"},{"key":"1030_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1517\/13543770902755129","volume":"19","author":"M Xia","year":"2009","unstructured":"Xia M, Sui Z. Recent developments in CCR2 antagonists. Expert Opin Ther Pat. 2009;19:295\u2013303","journal-title":"Expert Opin Ther Pat"},{"key":"1030_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/humupd\/dmv030","volume":"21","author":"AE Commandeur","year":"2015","unstructured":"Commandeur AE, Styer AK, Teixeira JM. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update. 2015;21:593\u2013615","journal-title":"Hum Reprod Update"},{"key":"1030_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","volume":"104","author":"EE Wallach","year":"2004","unstructured":"Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104:393\u2013406","journal-title":"Obstet Gynecol"},{"key":"1030_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/2230-8210.85575","volume":"15","author":"N Magon","year":"2011","unstructured":"Magon N. Gonadotropin releasing hormone agonists: expanding vistas. Indian J Endocrinol Metab. 2011;15:261\u20137","journal-title":"Indian J Endocrinol Metab"},{"key":"1030_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2165\/00003495-199651020-00009","volume":"51","author":"CM Perry","year":"1996","unstructured":"Perry CM, Brogden RN. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders. Drugs. 1996;51:319\u201346","journal-title":"Drugs"},{"key":"1030_CR15","unstructured":"Pelvic pain assessment form-old version 2004-English. International Pelvic Pain Society. https:\/\/www.pelvicpain.org\/IPPS\/Professional\/Documents-Forms\/IPPS\/Content\/Professional\/Documents_and_Forms.aspx?hkey=2597ab99-df83-40ee-89cd-7bd384efed19. Accessed 24 Dec 2019"},{"key":"1030_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.fertnstert.2007.01.093","volume":"87","author":"WH Parker","year":"2007","unstructured":"Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87:725\u201336","journal-title":"Fertil Steril"},{"key":"1030_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2188\/jea.12.249","volume":"12","author":"F Sato","year":"2002","unstructured":"Sato F, Mori M, Nishi M, Kudo R, Miyake H. Familial aggregation of uterine myomas in Japanese women. J Epidemiol. 2002;12:249\u201353","journal-title":"J Epidemiol"},{"key":"1030_CR18","first-page":"663","volume":"47","author":"BJ Van Voorhis","year":"2002","unstructured":"Van Voorhis BJ, Romitti PA, Jones MP. Family history as a risk factor for development of uterine leiomyomas. Results of a pilot study. J Reprod Med. 2002;47:663\u20139","journal-title":"J Reprod Med."},{"key":"1030_CR19","first-page":"528376","volume":"2013","author":"GP Flake","year":"2013","unstructured":"Flake GP, Moore AB, Sutton D, Kissling GE, Horton J, Wicker B, et al. The natural history of uterine leiomyomas: light and electron microscopic studies of fibroid phases, interstitial ischemia, inanosis, and reclamation. Obstet Gynecol Int. 2013;2013:528376","journal-title":"Obstet Gynecol Int"},{"key":"1030_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1210\/er.2012-1043","volume":"34","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev. 2013;34:130\u201362","journal-title":"Endocr Rev"},{"key":"1030_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361\u201371","journal-title":"Nat Rev Cancer"},{"key":"1030_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/humupd\/dmh019","volume":"10","author":"T Maruo","year":"2004","unstructured":"Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update. 2004;10:207\u201320","journal-title":"Hum Reprod Update"},{"key":"1030_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1365-2141.2001.02682.x","volume":"113","author":"M Suzuki","year":"2001","unstructured":"Suzuki M, Takamizawa S, Nomaguchi K, Suzu S, Yamada M, Igarashi T, et al. Erythropoietin synthesis by tumour tissues in a patient with uterine myoma and erythrocytosis. Br J Haematol. 2001;113:49\u201351","journal-title":"Br J Haematol"},{"key":"1030_CR24","first-page":"2275","volume":"86","author":"O Kurachi","year":"2001","unstructured":"Kurachi O, Matsuo H, Samoto T, Maruo T. Tumor necrosis factor-\u03b1 expression in human uterine leiomyoma and its down-regulation by progesterone. J Clin Endocrinol Metab. 2001;86:2275\u201380","journal-title":"J Clin Endocrinol Metab"},{"key":"1030_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/2058738418779461","author":"M Ciebiera","year":"2018","unstructured":"Ciebiera M, W\u0142odarczyk M, Wrzosek M, Wojty\u0142a C, B\u0142a\u017cej M, Nowicka G, et al. TNF-\u03b1 serum levels are elevated in women with clinically symptomatic uterine fibroids. Int J Immunopathol Pharmacol. 2018. https:\/\/doi.org\/10.1177\/2058738418779461","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1030_CR26","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1172\/JCI117933","volume":"95","author":"RP Negus","year":"1995","unstructured":"Negus RP, Stamp GW, Relf MG, Burke F, Malik ST, Bernasconi S, et al. The detection and localization of monocyte chemoattractant ~ rotein-1 (MCP-1) in human ovarian cancer. J Clin Invest. 1995;95:2391\u20136","journal-title":"J Clin Invest"},{"key":"1030_CR27","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/humrep\/deg356","volume":"18","author":"GF Meresman","year":"2003","unstructured":"Meresman GF, Bilotas MA, Lombardi E, Tesone M, Sueldo C, Bara\u00f1ao RI. Effect of GnRH analogues on apoptosis and release of interleukin-1beta and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum Reprod. 2003;18:1767\u201371","journal-title":"Hum Reprod"},{"key":"1030_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1071-55760300004-2","volume":"10","author":"N Chegini","year":"2003","unstructured":"Chegini N, Verala J, Luo X, Xu J, Williams RS. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Investig. 2003;10:161\u201371","journal-title":"J Soc Gynecol Investig"},{"key":"1030_CR29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1210\/en.2004-1384","volume":"146","author":"X Luo","year":"2005","unstructured":"Luo X, Ding L, Xu J, Williams RS, Chegini N. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy. Endocrinology. 2005;146:1074\u201396","journal-title":"Endocrinology"},{"key":"1030_CR30","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1126\/science.1112063","volume":"308","author":"CL Walker","year":"2005","unstructured":"Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308:1589\u201392","journal-title":"Science"},{"key":"1030_CR31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/humrep\/dep437","volume":"25","author":"KN Khan","year":"2010","unstructured":"Khan KN, Kitajima M, Hiraki K, Fujishita A, Sekine I, Ishimaru T, et al. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum Reprod. 2010;25:642\u201353","journal-title":"Hum Reprod"},{"key":"1030_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jri.2011.04.011","volume":"90","author":"S Matsui","year":"2011","unstructured":"Matsui S, Yasui T, Uemura H, Yamamoto S, Matsuzaki T, Tsuchiya N, et al. Induction of circulating monocyte chemoattractant protein-1 in women with gonadotropin-releasing hormone agonist. J Reprod Immunol. 2011;90:227\u201334","journal-title":"J Reprod Immunol"},{"key":"1030_CR33","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1471-0528.1994.tb11919.x","volume":"101","author":"MA Lumsden","year":"1994","unstructured":"Lumsden MA, West CP, Thomas E, Coutts J, Hillier H, Thomas N, et al. Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids. Br J Obstet Gynaecol. 1994;101:438\u201342","journal-title":"Br J Obstet Gynaecol"},{"key":"1030_CR34","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0020-7292(01)00458-1","volume":"74","author":"S Duffy","year":"2001","unstructured":"Duffy S. Chronic pelvic pain: defining the scope of the problem. Int J Gynaecol Obstet. 2001;74:S3\u20137","journal-title":"Int J Gynaecol Obstet"},{"key":"1030_CR35","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.pain.2007.06.020","volume":"132","author":"PT Weijenborg","year":"2007","unstructured":"Weijenborg PT, Greeven A, Dekker FW, Peters AA, Ter Kuile MM. Clinical course of chronic pelvic pain in women. Pain. 2007;132:S117\u2013S12323","journal-title":"Pain"},{"key":"1030_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0015-0282(16)56039-7","volume":"60","author":"P Vercellini","year":"1993","unstructured":"Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril. 1993;60:75\u20139","journal-title":"Fertil Steril"},{"key":"1030_CR37","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/humrep\/16.5.931","volume":"16","author":"ME Soysal","year":"2001","unstructured":"Soysal ME, Soysal S, Vicdan K, Ozer S. A randomized controlled trial of goserelin and medroxyprogesterone acetate in the treatment of pelvic congestion. Hum Reprod. 2001;16:931\u20139","journal-title":"Hum Reprod"},{"key":"1030_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0015-0282(16)59288-7","volume":"48","author":"CP West","year":"1987","unstructured":"West CP, Lumsden MA, Lawson S, Williamson J, Baird DT. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil Steril. 1987;48:45\u201351","journal-title":"Fertil Steril"},{"key":"1030_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5530\/jyp.2018.10.48","volume":"10","author":"A Al-Taie","year":"2018","unstructured":"Al-Taie A, K\u00f6seo\u011flu A. Incidence of early related\u2013complications of port-A catheter and impact of clinical pharmacist participation and counselling outcomes. J Young Pharm. 2018;10:218\u201321","journal-title":"J Young Pharm"},{"key":"1030_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.5530\/jyp.2019.11.89","volume":"11","author":"A Al-Taie","year":"2019","unstructured":"Al-Taie A, K\u00f6seo\u011flu A. Determination of radiotherapy-related acute side effects; a starting point for the possible implementation of a clinical pharmacy services in the radiological unit in turkey. J Young Pharm. 2019;11:434\u20138","journal-title":"J Young Pharm"},{"key":"1030_CR41","first-page":"130","volume":"18","author":"A Al-Taie","year":"2016","unstructured":"Al-Taie A, Abdulrazzaq HA, Y\u0131lmaz ZK, Izzettin FV, Koramaz N, Y\u0131lmaz KC. Differences in patients' self-reporting types to adverse symptomatic events. Eur J Clin Pharm. 2016;18:130\u20135","journal-title":"Eur J Clin Pharm"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01030-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-020-01030-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01030-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:05:13Z","timestamp":1619654713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-020-01030-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1030"],"URL":"https:\/\/doi.org\/10.1007\/s11096-020-01030-3","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"assertion":[{"value":"27 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}